...The most recent is a complaint filed Jan. 30 by Allergan and its Botox partner Medytox against Evolus and Daewoong, partners in Jeuveau, the biologic approved last week that will compete for some of Botox $3.6 billion yearly haul.
The complaint, filed with the United States International Trade Commission, alleged that a former Medytex employee stole trade secrets on the complex manufacturing process needed to turn botulism into a drug, as well as a sample of Medytex’ strain, Bloomberg reported.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.